Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies

BACKGROUND: There are an abundance of commercially available lateral flow assays (LFAs) that detect antibodies to SARS-CoV-2. Whilst these are usually evaluated by the manufacturer, externally performed diagnostic accuracy studies to assess performance are essential. Herein we present an evaluation...

Descripción completa

Detalles Bibliográficos
Autores principales: Owen, Sophie I., Williams, Christopher T., Garrod, Gala, Fraser, Alice J., Menzies, Stefanie, Baldwin, Lisa, Brown, Lottie, Byrne, Rachel L., Collins, Andrea M., Cubas-Atienzar, Ana I., de Vos, Margaretha, Edwards, Thomas, Escadafal, Camille, Ferreira, Daniela M., Fletcher, Tom, Hyder-Wright, Angela, Kay, Grant A., Kontogianni, Konstantina, Mason, Jenifer, Mitsi, Elena, Planche, Tim, Sacks, Jilian A., Taylor, Joseph, Todd, Stacy, Tully, Caroline, Cuevas, Luis E., Adams, Emily R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: W.B. Saunders 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664720/
https://www.ncbi.nlm.nih.gov/pubmed/34906597
http://dx.doi.org/10.1016/j.jinf.2021.12.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664720/
https://www.ncbi.nlm.nih.gov/pubmed/34906597
http://dx.doi.org/10.1016/j.jinf.2021.12.007

Ejemplares similares